VS-002

N/A

Report date: 2025/03/12 16:39:06
NME

Base Information

Drug NameVS-002
Drug Alias NameVS-002VP-002
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulatorsSodium/hydrogen exchanger 3 modulatorsChloride channel modulators
TargetsCystic fibrosis transmembrane conductance regulatorSodium/hydrogen exchanger 3Chloride channel
Therapy Area/IndicationsDiarrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida Research Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesNuvara Therapeutics
Inactive CompaniesN/A
Active IndicationsDiarrhea
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A